News und Analysen
LivaNova Initiates Targeted Commercial Launch of the Essenz Patient Monitor for Cardiopulmonary Bypass Procedures
LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced receipt of regulatory approvals and the start of a targeted commercial launch for the
Agilent Highlights Genomics and Cell Analysis Solutions for Cancer Research at AACR 2022
Agilent Technologies Inc. (NYSE: A) today announced cancer research innovations in cell analysis and genomics that will be on show at the American Association for Cancer Research Annual Meeting
Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022
Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that two abstracts featuring non-clinical data from studies evaluating FAP-2286 and Rubraca and a Trial-in-Progress poster detailing the Phase
Novocure Announces 19 Presentations at American Association for Cancer Research (AACR) Annual Meeting 2022 Suggesting Broad Applicability of Tumor Treating Fields
Novocure (NASDAQ: NVCR) today announced 19 presentations on Tumor Treating Fields (TTFields) will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2022, to be held
DGAP-News: Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb
DGAP-News: Evotec erreicht Programmauswahl in Neurologie-Kooperation mit Bristol Myers Squibb
Quidel Announces Preliminary Revenue for First Quarter 2022
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.P
Website
Chemed To Report First-Quarter 2022 Earnings April 26, Related Conference Call To Be Held On April 27
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the close of trading on the
Dexcom Publishes Annual Sustainability Report
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today released its third annual Sustainability Report. This report
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the publication of its 2021 Corporate Citizenship Report. The 2021 report demonstrates Charles River’s priorities and
DGAP-HV: STRATEC SE: Bekanntmachung der Einberufung zur Hauptversammlung am 20.05.2022 in Virtuelle Hauptversammlung mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Pfizer Inc. (NYSE: PFE) and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately held, clinical-stage
ABIONYX Pharma Reports Positive Interim Results From Phase 2a Clinical Trial Evaluating CER-001 in the Treatment of Septic Patients at High Risk of Developing Acute Kidney Injury
Regulatory News:
ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today
DGAP-News: Biotest AG: Biotest submits marketing authorisation application for IgG Next Generation and signed first licensing agreement
DGAP-News: Biotest AG: Biotest reicht Zulassungsantrag für IgG Next Generation ein und unterzeichnet ersten Lizenzvertrag
AEVIS VICTORIA SA - Ordinary General Meeting of Shareholders on 28 April 2022
AEVIS VICTORIA SA - Ordentliche Generalversammlung vom 28. April 2022
DGAP-News: Gerresheimer AG: Gerresheimer hebt nach starkem 1. Quartal Umsatzprognose für 2022 auf zweistelliges Wachstum an
DGAP-News: Gerresheimer AG: Gerresheimer raises revenue guidance for 2022 to double-digit growth after strong first quarter
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its second
AMN Healthcare to Hold First Quarter 2022 Earnings Conference Call on Thursday, May 5, 2022
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call to discuss its first quarter 2022 financial results and second quarter 2022 outlook on Thursday, May 5, 2022 at 5:00 p.m
New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+
According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles – a painful rash – compared to those who haven’t been
Charles River Laboratories Acquires Explora BioLabs
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired Explora BioLabs Holdings, Inc., a premier provider of contract vivarium research services.
Based in
Silence Therapeutics to Present at 21st Annual Needham Virtual Healthcare Conference
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the